How Zeelab Is Turning Its Affordable Pharma Play Into A ₹200 Cr Business
For most consumer businesses, a lower price is a unique selling proposition (USP). But for Zeelab Pharmacy founder and CEO Rohit Mukul, it is a more fundamental need and a way to correct a market where consumers have historically had little choice.
Worth a read for people-focused operators. Published by Inc42 — context above is the source's own framing.
For most consumer businesses, a lower price is a unique selling proposition (USP). But for Zeelab Pharmacy founder and CEO Rohit Mukul, it is a more fundamental need and a way to correct a market where consumers have historically had little choice.
This article lives at Inc42. We linked it because we found it valuable for F&B operators.
Contributor
Curated industry coverage by the Restronomics editorial team. Each article is selected from approved F&B publications and includes a Restronomics editor take.
India’s startup funding market opened September on a softer note, extending its decline for a second straight week. Between August 31 and September 4, 22 startups raised a combined $176.5 Mn, down 16% from the $210.3 Mn raised across 23 deals in the previous week.
Restaurant Industry Intelligence
Data-driven insights, trends, and analysis for food & beverage professionals.
Subscribe Free